These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 38946194

  • 1. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia.
    Fang H, Wang SA, Beird HC, Tang Z, You MJ, Li S, Xu J, Hu S, Yin CC, El Hussein S, Lin P, Jelloul FZ, Vega F, Medeiros LJ, Wang W.
    Am J Clin Pathol; 2024 Jun 30. PubMed ID: 38946194
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia].
    Yu YP, Wang LP, Song P, Mei JG, An ZM, Zhou XG, Li F, Tang YM, Zhai YP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb 30; 25(1):8-15. PubMed ID: 28245368
    [Abstract] [Full Text] [Related]

  • 3. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
    Sugimoto T, Imoto S, Matsuo Y, Kojima K, Yasukawa M, Murayama T, Kohfuku J, Mizuno I, Yakushijin K, Sada A, Nishimura R, Koizumi T.
    Ann Hematol; 2001 Dec 30; 80(12):749-51. PubMed ID: 11797117
    [Abstract] [Full Text] [Related]

  • 4. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
    Hu Z, Medeiros LJ, Xu M, Yuan J, Peker D, Shao L, Tang Z, Mai B, Thakral B, Rios A, Hu S, Wang W.
    Am J Clin Pathol; 2023 Apr 04; 159(4):325-336. PubMed ID: 36883805
    [Abstract] [Full Text] [Related]

  • 5. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia.
    Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA.
    J Clin Pathol; 2018 Apr 04; 71(4):309-315. PubMed ID: 28821581
    [Abstract] [Full Text] [Related]

  • 6. Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.
    Toyota S, Nakamura N, Dan K.
    Int J Hematol; 2005 Jan 04; 81(1):66-8. PubMed ID: 15717692
    [Abstract] [Full Text] [Related]

  • 7. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
    Gujral S, Polampalli S, Badrinath Y, Kumar A, Subramanian PG, Nair R, Sengar M, Nair C.
    Indian J Cancer; 2010 Jan 04; 47(2):189-93. PubMed ID: 20448385
    [Abstract] [Full Text] [Related]

  • 8. Advances in the understanding and management of T-cell prolymphocytic leukemia.
    Laribi K, Lemaire P, Sandrini J, Baugier de Materre A.
    Oncotarget; 2017 Nov 28; 8(61):104664-104686. PubMed ID: 29262669
    [Abstract] [Full Text] [Related]

  • 9. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
    Tamayose K, Sato N, Ando J, Sugimoto K, Oshimi K.
    Am J Hematol; 2002 Dec 28; 71(4):331-5. PubMed ID: 12447967
    [Abstract] [Full Text] [Related]

  • 10. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
    Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, Jones D.
    Blood; 2008 Jan 01; 111(1):328-37. PubMed ID: 17890451
    [Abstract] [Full Text] [Related]

  • 11. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
    Hu Z, Li S, Medeiros LJ, Sun T.
    Hum Pathol; 2017 Jul 01; 65():175-179. PubMed ID: 28232160
    [Abstract] [Full Text] [Related]

  • 12. A case of T cell prolymphocytic leukemia involving blast transformation.
    Ichikawa K, Noguchi M, Imai H, Sekiguchi Y, Wakabayashi M, Sawada T, Komatsu N.
    Int J Hematol; 2011 May 01; 93(5):667-672. PubMed ID: 21505955
    [Abstract] [Full Text] [Related]

  • 13. CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up.
    Gilles SR, Yohe SL, Linden MA, Dolan M, Hirsch B, Grzywacz B.
    Am J Clin Pathol; 2019 Sep 09; 152(4):471-478. PubMed ID: 31305900
    [Abstract] [Full Text] [Related]

  • 14. T-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.
    Yoshioka Y, Nagao M, Saitoh T, Yoshioka S, Tsunemine H, Itoh K, Kodaka T, Takahashi T.
    J Clin Exp Hematop; 2015 Sep 09; 55(1):17-21. PubMed ID: 26106002
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count].
    Shimizu M, Tsuboi Y, Kuroda A, Seki M, Shinagawa A.
    Rinsho Ketsueki; 2024 Sep 09; 65(6):487-491. PubMed ID: 38960645
    [Abstract] [Full Text] [Related]

  • 18. Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia.
    Gritti C, Dastot H, Soulier J, Janin A, Daniel MT, Madani A, Grimber G, Briand P, Sigaux F, Stern MH.
    Blood; 1998 Jul 15; 92(2):368-73. PubMed ID: 9657733
    [Abstract] [Full Text] [Related]

  • 19. [T-cell prolymphocytic leukemia complicated by diffuse large B-cell lymphoma of the stomach].
    Miyata A, Yoshino T, Kojima K, Fujii S, Kikuchi T.
    Rinsho Ketsueki; 2001 Jan 15; 42(1):47-50. PubMed ID: 11235134
    [Abstract] [Full Text] [Related]

  • 20. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP, Variakojis D, Peterson LC.
    Mod Pathol; 2002 Nov 15; 15(11):1111-20. PubMed ID: 12429788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.